Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 36.72
-0.74 (-1.98%)
At close: Jun 17, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 221.35 million as of June 18, 2026. Its market cap has increased by 774.29% in one year.
Market Cap
221.35M
Enterprise Value
235.92M
Revenue
12.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.72
Market Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 221.35M, a decrease of -50.10%. That is a compound annual growth rate of -5.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 221.35M | 716.00% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Welcure Drugs and Pharmaceuticals | 333.70M |
| JFL Life Sciences | 311.81M |
| Deccan Health Care | 306.41M |
| Gujarat Terce Laboratories | 254.93M |
| Hamps Bio | 225.21M |
| Parmax Pharma | 221.93M |
| Walpar Nutritions | 217.86M |
| Cian Healthcare | 206.50M |